US Stock MarketDetailed Quotes

DCPH Deciphera Pharmaceuticals

Watchlist
  • 14.650
  • +0.470+3.31%
Close Apr 26 16:00 ET
  • 14.650
  • 0.0000.00%
Post 16:20 ET
1.20BMarket Cap-6397P/E (TTM)

Deciphera Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
21.87%163.36M
32.88%48.29M
20.40%43.31M
17.88%38.3M
14.45%33.45M
39.41%134.04M
50.19%36.35M
54.93%35.97M
37.84%32.49M
16.17%29.22M
Operating revenue
21.87%163.36M
32.88%48.29M
20.40%43.31M
17.88%38.3M
14.45%33.45M
39.41%134.04M
50.19%36.35M
54.93%35.97M
37.84%32.49M
16.17%29.22M
Cost of revenue
-57.45%3.73M
-44.99%1.79M
-61.54%1.29M
-90.38%173K
27.75%488K
199.11%8.77M
526.45%3.25M
264.67%3.34M
41.10%1.8M
72.07%382K
Gross profit
27.43%159.62M
40.51%46.51M
28.80%42.03M
24.23%38.13M
14.27%32.96M
34.38%125.27M
39.77%33.1M
46.30%32.63M
37.66%30.7M
15.67%28.84M
Operating expense
20.32%370.58M
21.79%97.75M
23.49%95.72M
22.05%90.91M
13.84%86.21M
-21.69%307.99M
-28.39%80.26M
-23.99%77.51M
-19.75%74.48M
-12.37%75.73M
Selling and administrative expenses
13.56%136.46M
21.60%39.15M
10.74%33.25M
10.08%32.61M
11.04%31.45M
-11.81%120.17M
-13.34%32.2M
-15.48%30.03M
-9.76%29.63M
-7.89%28.32M
Research and development costs
24.65%234.12M
21.91%58.6M
31.54%62.46M
29.96%58.3M
15.51%54.77M
-26.93%187.82M
-35.85%48.07M
-28.53%47.49M
-25.22%44.86M
-14.85%47.41M
Operating profit
-15.45%-210.96M
-8.64%-51.24M
-19.62%-53.69M
-20.52%-52.78M
-13.57%-53.26M
39.11%-182.72M
46.65%-47.16M
43.66%-44.88M
37.90%-43.79M
23.75%-46.89M
Net non-operating interest income expense
264.44%16.45M
129.93%4.48M
123.45%4.11M
479.50%4.21M
3.65M
3,893.81%4.51M
32,366.67%1.95M
1,181.18%1.84M
797.53%727K
0
Non-operating interest income
264.44%16.45M
129.93%4.48M
123.45%4.11M
479.50%4.21M
--3.65M
3,893.81%4.51M
32,366.67%1.95M
--1.84M
797.53%727K
--0
Other net income (expense)
Income before tax
-9.15%-194.51M
-3.42%-46.76M
-15.19%-49.58M
-12.77%-48.56M
-5.79%-49.61M
40.59%-178.21M
48.85%-45.21M
46.09%-43.04M
38.86%-43.06M
23.50%-46.89M
Income tax
-40.30%431K
722K
Net income
-8.95%-194.94M
-2.73%-47.19M
-15.19%-49.58M
-12.77%-48.56M
-5.79%-49.61M
40.35%-178.93M
48.03%-45.94M
46.09%-43.04M
38.86%-43.06M
23.50%-46.89M
Net income continuous Operations
-8.95%-194.94M
-2.73%-47.19M
-15.19%-49.58M
-12.77%-48.56M
-5.79%-49.61M
40.35%-178.93M
48.03%-45.94M
46.09%-43.04M
38.86%-43.06M
23.50%-46.89M
Minority interest income
Net income attributable to the parent company
-8.95%-194.94M
-2.73%-47.19M
-15.19%-49.58M
-12.77%-48.56M
-5.79%-49.61M
40.35%-178.93M
48.03%-45.94M
46.09%-43.04M
38.86%-43.06M
23.50%-46.89M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-8.95%-194.94M
-2.73%-47.19M
-15.19%-49.58M
-12.77%-48.56M
-5.79%-49.61M
40.35%-178.93M
48.03%-45.94M
46.09%-43.04M
38.86%-43.06M
23.50%-46.89M
Basic earnings per share
3.38%-2.29
10.00%-0.54
-5.45%-0.58
5.00%-0.57
25.00%-0.6
54.07%-2.37
60.26%-0.6
59.85%-0.55
50.41%-0.6
24.53%-0.8
Diluted earnings per share
3.38%-2.29
10.00%-0.54
-5.45%-0.58
5.00%-0.57
25.00%-0.6
54.07%-2.37
60.26%-0.6
59.85%-0.55
50.41%-0.6
24.53%-0.8
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 21.87%163.36M32.88%48.29M20.40%43.31M17.88%38.3M14.45%33.45M39.41%134.04M50.19%36.35M54.93%35.97M37.84%32.49M16.17%29.22M
Operating revenue 21.87%163.36M32.88%48.29M20.40%43.31M17.88%38.3M14.45%33.45M39.41%134.04M50.19%36.35M54.93%35.97M37.84%32.49M16.17%29.22M
Cost of revenue -57.45%3.73M-44.99%1.79M-61.54%1.29M-90.38%173K27.75%488K199.11%8.77M526.45%3.25M264.67%3.34M41.10%1.8M72.07%382K
Gross profit 27.43%159.62M40.51%46.51M28.80%42.03M24.23%38.13M14.27%32.96M34.38%125.27M39.77%33.1M46.30%32.63M37.66%30.7M15.67%28.84M
Operating expense 20.32%370.58M21.79%97.75M23.49%95.72M22.05%90.91M13.84%86.21M-21.69%307.99M-28.39%80.26M-23.99%77.51M-19.75%74.48M-12.37%75.73M
Selling and administrative expenses 13.56%136.46M21.60%39.15M10.74%33.25M10.08%32.61M11.04%31.45M-11.81%120.17M-13.34%32.2M-15.48%30.03M-9.76%29.63M-7.89%28.32M
Research and development costs 24.65%234.12M21.91%58.6M31.54%62.46M29.96%58.3M15.51%54.77M-26.93%187.82M-35.85%48.07M-28.53%47.49M-25.22%44.86M-14.85%47.41M
Operating profit -15.45%-210.96M-8.64%-51.24M-19.62%-53.69M-20.52%-52.78M-13.57%-53.26M39.11%-182.72M46.65%-47.16M43.66%-44.88M37.90%-43.79M23.75%-46.89M
Net non-operating interest income expense 264.44%16.45M129.93%4.48M123.45%4.11M479.50%4.21M3.65M3,893.81%4.51M32,366.67%1.95M1,181.18%1.84M797.53%727K0
Non-operating interest income 264.44%16.45M129.93%4.48M123.45%4.11M479.50%4.21M--3.65M3,893.81%4.51M32,366.67%1.95M--1.84M797.53%727K--0
Other net income (expense)
Income before tax -9.15%-194.51M-3.42%-46.76M-15.19%-49.58M-12.77%-48.56M-5.79%-49.61M40.59%-178.21M48.85%-45.21M46.09%-43.04M38.86%-43.06M23.50%-46.89M
Income tax -40.30%431K722K
Net income -8.95%-194.94M-2.73%-47.19M-15.19%-49.58M-12.77%-48.56M-5.79%-49.61M40.35%-178.93M48.03%-45.94M46.09%-43.04M38.86%-43.06M23.50%-46.89M
Net income continuous Operations -8.95%-194.94M-2.73%-47.19M-15.19%-49.58M-12.77%-48.56M-5.79%-49.61M40.35%-178.93M48.03%-45.94M46.09%-43.04M38.86%-43.06M23.50%-46.89M
Minority interest income
Net income attributable to the parent company -8.95%-194.94M-2.73%-47.19M-15.19%-49.58M-12.77%-48.56M-5.79%-49.61M40.35%-178.93M48.03%-45.94M46.09%-43.04M38.86%-43.06M23.50%-46.89M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -8.95%-194.94M-2.73%-47.19M-15.19%-49.58M-12.77%-48.56M-5.79%-49.61M40.35%-178.93M48.03%-45.94M46.09%-43.04M38.86%-43.06M23.50%-46.89M
Basic earnings per share 3.38%-2.2910.00%-0.54-5.45%-0.585.00%-0.5725.00%-0.654.07%-2.3760.26%-0.659.85%-0.5550.41%-0.624.53%-0.8
Diluted earnings per share 3.38%-2.2910.00%-0.54-5.45%-0.585.00%-0.5725.00%-0.654.07%-2.3760.26%-0.659.85%-0.5550.41%-0.624.53%-0.8
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg